Vita Life Sciences Limited (VLS.AX)
Company Info
Highlights
A$103.76M
A$0.17
10.97
A$39.45M
A$22.99M
A$6.37M
A$1.76 - A$2.46
A$0.85
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of A$10,000 in Vita Life Sciences Limited, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Vita Life Sciences Limited had a return of -3.75% year-to-date (YTD) and 5.53% in the last 12 months. Over the past 10 years, Vita Life Sciences Limited had an annualized return of 6.48%, while the S&P 500 had an annualized return of 11.21%, indicating that Vita Life Sciences Limited did not perform as well as the benchmark.
VLS.AX
-3.75%
-0.77%
-14.66%
5.53%
31.68%
6.48%
^GSPC (Benchmark)
2.90%
3.70%
10.94%
22.18%
12.41%
11.21%
Monthly Returns
The table below presents the monthly returns of VLS.AX, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | -6.00% | -3.75% | |||||||||||
| 2024 | 6.74% | 13.16% | 15.48% | -10.33% | 3.69% | 1.34% | 0.44% | -4.37% | 3.38% | -3.59% | -6.51% | -0.50% | 17.03% |
| 2023 | 12.17% | -2.96% | 0.38% | 1.38% | 5.44% | 0.64% | -5.13% | 2.36% | 12.91% | 4.76% | -1.70% | 2.89% | 36.58% |
| 2022 | -5.52% | 32.03% | -1.23% | -9.09% | -10.95% | -3.74% | 13.89% | -7.81% | -13.96% | -2.50% | -3.85% | -9.67% | -26.55% |
| 2021 | 0.00% | -0.00% | -0.20% | 18.98% | 3.88% | -8.72% | -1.36% | 13.13% | 19.97% | 31.25% | -10.05% | 11.76% | 98.90% |
| 2020 | -2.99% | 0.00% | 0.40% | -4.76% | -5.00% | -1.75% | 16.97% | 34.34% | 0.46% | 2.29% | -1.13% | 13.64% | 57.08% |
| 2019 | -2.07% | -9.47% | -1.53% | 5.45% | -3.45% | -13.69% | -2.07% | -8.45% | 0.95% | -5.47% | 1.65% | 8.95% | -27.32% |
| 2018 | 0.64% | -3.84% | 0.79% | 3.41% | 3.95% | 0.63% | -11.32% | 7.80% | 26.81% | 0.00% | 0.53% | 1.57% | 30.61% |
| 2017 | -5.01% | -3.26% | -5.36% | -4.98% | -3.81% | 3.96% | 3.81% | -8.26% | -3.55% | -3.15% | -14.14% | -1.90% | -38.08% |
| 2016 | 18.71% | -10.61% | 23.08% | -14.52% | -8.83% | -3.94% | -1.48% | -5.69% | 24.21% | -1.96% | -12.01% | -1.89% | -4.50% |
| 2015 | 1.35% | 2.66% | -5.57% | 2.44% | -4.76% | -3.57% | -7.41% | -35.20% | 26.70% | 8.91% | 0.91% | 25.22% | -3.30% |
| 2014 | -9.49% | 22.38% | 2.60% | -5.07% | -5.94% | -2.21% | 3.22% | 1.56% | -2.18% | -4.76% | -0.00% | -1.34% | -4.37% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of VLS.AX is 51, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Vita Life Sciences Limited (VLS.AX) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Vita Life Sciences Limited provided a 4.94% dividend yield over the last twelve months, with an annual payout of A$0.10 per share. The company has been increasing its dividends for 13 consecutive years.
| Period | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | A$0.10 | A$0.10 | A$0.06 | A$0.06 | A$0.06 | A$0.04 | A$0.04 | A$0.04 | A$0.04 | A$0.04 | A$0.04 | A$0.04 |
Dividend yield | 4.94% | 4.75% | 3.51% | 4.24% | 2.89% | 3.75% | 5.60% | 3.87% | 4.84% | 2.90% | 2.52% | 2.36% |
Monthly Dividends
The table displays the monthly dividend distributions for Vita Life Sciences Limited. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | A$0.00 | A$0.00 | A$0.00 | ||||||||||
| 2024 | A$0.00 | A$0.00 | A$0.06 | A$0.00 | A$0.00 | A$0.00 | A$0.00 | A$0.00 | A$0.04 | A$0.00 | A$0.00 | A$0.00 | A$0.10 |
| 2023 | A$0.00 | A$0.00 | A$0.03 | A$0.00 | A$0.00 | A$0.00 | A$0.00 | A$0.00 | A$0.03 | A$0.00 | A$0.00 | A$0.00 | A$0.06 |
| 2022 | A$0.00 | A$0.00 | A$0.03 | A$0.00 | A$0.00 | A$0.00 | A$0.00 | A$0.00 | A$0.03 | A$0.00 | A$0.00 | A$0.00 | A$0.06 |
| 2021 | A$0.00 | A$0.00 | A$0.03 | A$0.00 | A$0.00 | A$0.00 | A$0.00 | A$0.00 | A$0.03 | A$0.00 | A$0.00 | A$0.00 | A$0.06 |
| 2020 | A$0.00 | A$0.00 | A$0.02 | A$0.00 | A$0.00 | A$0.00 | A$0.00 | A$0.00 | A$0.02 | A$0.00 | A$0.00 | A$0.00 | A$0.04 |
| 2019 | A$0.00 | A$0.00 | A$0.02 | A$0.00 | A$0.00 | A$0.00 | A$0.00 | A$0.00 | A$0.02 | A$0.00 | A$0.00 | A$0.00 | A$0.04 |
| 2018 | A$0.00 | A$0.00 | A$0.02 | A$0.00 | A$0.00 | A$0.00 | A$0.00 | A$0.00 | A$0.02 | A$0.00 | A$0.00 | A$0.00 | A$0.04 |
| 2017 | A$0.00 | A$0.00 | A$0.02 | A$0.00 | A$0.00 | A$0.00 | A$0.00 | A$0.00 | A$0.02 | A$0.00 | A$0.00 | A$0.00 | A$0.04 |
| 2016 | A$0.00 | A$0.00 | A$0.02 | A$0.00 | A$0.00 | A$0.00 | A$0.00 | A$0.00 | A$0.02 | A$0.00 | A$0.00 | A$0.00 | A$0.04 |
| 2015 | A$0.00 | A$0.00 | A$0.02 | A$0.00 | A$0.00 | A$0.00 | A$0.00 | A$0.00 | A$0.02 | A$0.00 | A$0.00 | A$0.00 | A$0.04 |
| 2014 | A$0.02 | A$0.00 | A$0.00 | A$0.00 | A$0.00 | A$0.00 | A$0.02 | A$0.00 | A$0.00 | A$0.00 | A$0.04 |
Dividend Yield & Payout
Dividend Yield
Payout Ratio
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the Vita Life Sciences Limited. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Vita Life Sciences Limited was 75.04%, occurring on Dec 17, 2008. Recovery took 120 trading sessions.
The current Vita Life Sciences Limited drawdown is 20.55%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -75.04% | Jul 14, 2008 | 113 | Dec 17, 2008 | 120 | Jun 12, 2009 | 233 |
| -64.91% | Mar 29, 2016 | 1049 | May 19, 2020 | 351 | Oct 4, 2021 | 1400 |
| -58.33% | Apr 9, 2010 | 1 | Apr 9, 2010 | 184 | Dec 29, 2010 | 185 |
| -58.14% | Sep 10, 2013 | 496 | Aug 25, 2015 | 147 | Mar 22, 2016 | 643 |
| -46.32% | Mar 7, 2022 | 203 | Dec 21, 2022 | 311 | Mar 18, 2024 | 514 |
Volatility
Volatility Chart
The current Vita Life Sciences Limited volatility is 11.27%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Historical P/E Ratio Chart
The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Vita Life Sciences Limited.
Loading data...
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |